Navigation Links
Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast
Date:2/18/2009

OMAHA, Neb., Feb. 18 /PRNewswire-FirstCall/ -- Transgenomic Inc. (OTC Bulletin Board: TBIO) announces the following Webcast:

    What:     Transgenomic Inc. Fourth Quarter 2008 Earnings Release
              Conference Call

    When:     Wednesday, February 25, 2009 @ 5:00 p.m. Eastern

    Where:   http://www.transgenomic.com/events.asp?id=6

    How:      Live over the Internet -- Simply log on to the web at the
              address above.

To access the call via telephone, call 800-894-5910 or 785-424-1052. A replay of the call will be available via telephone until 11:59 pm ET on Wednesday, March 11, 2009. To access, dial 800-677-7320 or 402-220-0666.

About Transgenomic:

Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems, related consumables and assay kits, cytogenetics automated systems, Transgenomic Molecular Clinical Reference Laboratory and Pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: www.transgenomic.com.


'/>"/>
SOURCE Transgenomic Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast
2. Palatin Technologies to Report Fiscal Year 2009 Second Quarter Results; Conference Call and Webcast on February 17, 2009
3. Cell Therapeutics, Inc. (CTI) BIO CEO Presentation to be Webcast
4. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2008 Earnings and 2009 Guidance Release, Webcast and Conference Call
5. GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference
6. Alexzas Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference
7. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
8. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
9. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
10. BioMarin to Host Fourth Quarter and Full Year 2008 Financial Results Conference Call and Webcast on Wednesday, February 18 at 5:00 p.m. ET (23:00 CET)
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 iLab ... announced the appointment of Siri Bryant as the new ... new Director of Core Implementations. These two new leadership ... outstanding customer service by ensuring that iLab continues to ... “In the last four years, iLab has been deployed ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... dental biomaterial market will grow moderately through ... implant procedures and growing awareness of dental biomaterials all ... underdeveloped markets such as China ... incomes will bring dental procedures within reach for a ...
(Date:12/17/2014)... (PRWEB) December 16, 2014 The ... since 2013, which is why IBISWorld updated its original ... continues to benefit from an intensified focus on environmental ... for new emission standards for power plants and a ... According to IBISWorld Industry Analyst Sarah Kahn, “a range ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
... Calif., Nov. 4, 2010 Onda Corporation, the global ... markets, introduced the latest additions to the hydrophone product ... The HFO-660 is a new fiber optic hydrophone system ... for emerging applications of HITU. It is complemented with ...
... EDISON, N.J., Nov. 4, 2010 International Technidyne Corporation ... THOR ), announced today the completion of its ... private equity firm, in an all cash transaction valued ... leader in hemostasis management and Point-of-Care (POC) testing for ...
... HOUSTON ― An antibody loaded with an anti-cancer agent produced ... relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I ... the New England Journal of Medicine . "That ... a Phase I trial," said study lead author Anas Younes, ...
Cached Biology Technology:Onda Introduces a New Fiber Optic Hydrophone and Scanning Tank 2International Technidyne Corporation Acquired by Warburg Pincus 2International Technidyne Corporation Acquired by Warburg Pincus 3Armed antibody triggers remissions for Hodgkin's lymphoma 2Armed antibody triggers remissions for Hodgkin's lymphoma 3
(Date:12/10/2014)... 2014  Wake Forest Baptist Medical Center today announced plans ... of Medicine. Funding for this $50 million capital project ... be publicly launched next summer. The ... 60 series R.J. Reynolds Tobacco Company complex, adjacent to ... immediately with plans to be ready to welcome medical ...
(Date:12/5/2014)... Calif. , Dec. 4, 2014 ... has boosted investments in new testing and inspection ... also given rise to a range of innovative ... the requirements of Generation Y, which is generally ... As a result, product development strategies of test ...
(Date:12/3/2014)... -- As part of our commitment to offering the ... announce the release of a new reader that will ... data that they need. The Atlas 2000 ... readers. Many such devices have serious shortcomings when it ... models force users to navigate numerous complicated steps in ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
... PROVIDENCE, R.I. [Brown University] It,s been long known ... cells stabbed with spiky, long asbestos fibers, and the image ... cell, like a quivering arrow that,s found its mark. ... be interested in asbestos fibers and other materials at the ...
... ITHACA, N.Y. With an eye toward understanding DNA ... to actually unzip the two strands of DNA. (Nature, online ... processes, including DNA replication, are enzymes called helicases. Acting like ... prompting the strands to "zip" apart. What had been ...
... already led to major shifts in the abundance of commercially ... on September 15 in Current Biology , a Cell ... abundance of species as opposed to their presence or absence ... well on the European shelf than more northerly, cold-adapted species," ...
Cached Biology News:Why carbon nanotubes spell trouble for cells 2For unzipping DNA mysteries -- literally -- Cornell physicists discover how a vital enzyme works 2In rapidly warming seas, some fish lose while others gain 2
Immunogen: Synthetic peptide: N(171) H G F L S A D Q QL I K(183) Storage: -20 C, Avoid Freeze/Thaw Cycles...
The pCDF Expression System 1 plus Competent Cells contains 10 µg of pET-45b(+) DNA. pET-45b carries an N-terminal His•Tag ® coding sequence that is cleavable with enterokinase as well...
HIV-1 TAT (vN-21)...
Request Info...
Biology Products: